HEPA

Hepion Pharmaceuticals
HEPA

Delisted

HEPA was delisted on the 12th of May, 2025.

Back to rankings

16 hedge funds and large institutions have $215K invested in Hepion Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $
Holders
16
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$6.59K
2
+$5.36K
3
+$376

Top Sellers

1
-$19.6K
2
-$19.1K
3
-$870
4
TRCT
Tower Research Capital (TRC)
New York
-$495
5
AF
Advisornet Financial
Minnesota
-$42
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$89.9K
2
$39K
3
$23.6K
4
$21.2K
5
$12.2K
6
$8.16K
7
$7.37K
8
$6.59K
9
$3.63K
10
$2.74K
11
$637
12
$82
13
$59
14
$53
15
$39
16
$26
17
$1
18
–
19
–
20
–
21
–
22
–